Rapamycin in With High-Dose Etoposide & Cytarabine in Relapsed/Refractory

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05016947` - Venetoclax Plus Inotuzumab for B-ALL	Phase 1
Recruiting	`NCT05009537` - Optical Genome Mapping in Hematological Malignancies
Terminated	`NCT01230788` - Rituximab for Patients With Relapsed Acute Lymphoblastic Leukemia	N/A
Completed	`NCT00333190` - CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation	N/A
Recruiting	`NCT05461625` - ACL Reconstruction With/Without ALL Reconstruction	N/A
Recruiting	`NCT02990572` - Amish/Mennonite Research Contact Registry
Completed	`NCT02631993` - Photochemotherapy and Graft-versus-leukemia in Acute-leukemia	N/A
Completed	`NCT00863148` - Allogeneic Stem Cell Transplant With Clofarabine, Busulfan and Antithymocyte Globulin (ATG) for Adult Patients With High-risk Acute Myeloid Leukemia/Myelodysplastic Syndromes (AML/MDS) or Acute Lymphoblastic Leukemia (ALL)	Phase 2
Recruiting	`NCT04601584` - GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL	Phase 1/Phase 2
Not yet recruiting	`NCT05592470` - commd7 Gene Expression in ALL
Recruiting	`NCT02861209` - Collaborative Network to Take Responsibility for Oral Anticancer Therapy	N/A
Completed	`NCT01012492` - Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT	Phase 2
Recruiting	`NCT04644016` - Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders	Phase 2
Recruiting	`NCT06131801` - Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Recruiting	`NCT05476770` - Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies	Phase 1
Recruiting	`NCT03571321` - Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia	Phase 1
Recruiting	`NCT05414162` - Multiparametric Cardiac MRI in Patients Under CAR T-cell Therapy
Active, not recruiting	`NCT03154346` - Project Baseline Health Study
Terminated	`NCT01532635` - A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives	Phase 2
Completed	`NCT01319864` - POETIC Plerixafor as a Chemosensitizing Agent for Relapsed Acute Leukemia and MDS in Pediatric Patients	Phase 1

NCT number	NCT00776373
Study type	Interventional
Source	Abramson Cancer Center of the University of Pennsylvania
Contact
Status	Terminated
Phase	Phase 1/Phase 2
Start date	January 2007
Completion date	December 2009

Rapamycin in With High-Dose Etoposide and Cytarabine in Relapsed/Refractory Aggressive Lymphoid Malignancies — UPCC 25406

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms